Status:
UNKNOWN
Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)
Lead Sponsor:
Goethe University
Collaborating Sponsors:
Nationwide Network of University Medicine (NUM) on Covid-19
Conditions:
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Eligibility:
All Genders
18+ years
Brief Summary
The intersectoral platform is part of the National Pandemic Cohort Network (NAPKON) and will be used to provide a comprehensive and harmonized collection of data and biomaterial for researchers from n...
Detailed Description
The intersectoral platform is part of the National Pandemic Cohort Network (NAPKON), which, together and in interaction with other components of the National Research Network of University Medicine on...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Compliance with the case definition (a-c):
- Polymerase chain reaction (PCR) or rapid test diagnosis from nasopharynx, bronchoalveolar lavage, oropharynx, stool and/or blood
- or a combination of:
- negative molecular detection of SARS-CoV-2 AND
- characteristic radiological findings AND
- respiratory tract infection AND
- absence of a more likely cause of disease, in particular other chronic lung diseases AND
- Negative test for influenza
- or (control group) a combination of:
- negative molecular detection of SARS-CoV-2 AND
- respiratory tract infection AND
- absence of a more likely cause of disease, in particular other chronic lung diseases AND
- attempt of pathogen identification from respiratory material with at least culture and influenza test
- The baseline visit needs to be performed a maximum of 7 days (168h) after sampling and 4 days (96h) after the case definition is available.
- Signed informed consent
Exclusion
- Age \<18 years
- Paediatric patients will not be included at the beginning of the study (amendment in preparation).
Key Trial Info
Start Date :
November 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
6550 Patients enrolled
Trial Details
Trial ID
NCT04768998
Start Date
November 4 2020
End Date
September 1 2023
Last Update
February 24 2021
Active Locations (34)
Enter a location and click search to find clinical trials sorted by distance.
1
RWTH Aachen
Aachen, Germany, 52074
2
University Hospital Augsburg
Augsburg, Germany, 86156
3
Charité Berlin
Berlin, Germany, 10117
4
Klinikum Bielefeld
Bielefeld, Germany, 33604